Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D
Succinyl-CoA plays an important role in the production of energy from lipids and proteins and is also required for the synthesis of hemoglobin, the oxygen-carrying pigment in red blood cells (3)
Some individuals report improvement in chronic conditions, while others note rashes or nonspecific irritation
doi: 10.1016/j.ijbiomac.2024.136309 16 HuangL
[3] In contrast, certain antidepressants may worsen glycaemic control
Individual biological variation in GLP-1 receptor sensitivity, metabolism, and hormonal regulation means that not everyone responds identically to the medication